STARR Life Sciences® Awarded Us Patent for Pulse Oximeters That Work on Animals with Heart Rates in Excess of 450 Beats Per Minute

STARR Life Sciences Corp. announces the award of Patent #8,005,624 by the US Patent and Trademark Office for a small animal pulse oximeter that works on animals with heart rates above 450 bpm. - October 06, 2011 - STARR Life Sciences Corp.

New Gold Renewal Program from Pipette.com Restores Value to Previously Unusable Instruments in Life Science Labs

Pipette.com is excited to announce the release of a new pipette service and calibration program. The Gold Renewal Program is a new and exclusive program to Pipette.com. This program is designed to restore damaged and broken pipettes that are unable to be used because of their current condition. The... - October 06, 2011 - Accutek Laboratories

Medical Laboratory Services, Medical Group, Inc. Awarded  CAP Accreditation

Medical Laboratory Services, Medical Group, Inc. Awarded CAP Accreditation

The accreditation Committee of the college of American Pathologist (CAP) awarded accreditation to Medical Laboratory Services Medical Group, Murrieta, California, based on the results of a recent on-site inspection. - October 04, 2011 - Medical Laboratory Services

Secure Patient Portal Technology Proves Successful for Award-Winning Virginia Women’s Center

Richmond, Virginia’s independent women’s health practice and 2009 recipient of the Davies Award, Virginia Women’s Center, continues to prove its commitment to technology through an online portal that allows for better patient care, faster test reporting and improved patient experience. - September 29, 2011 - Virginia Women's Center

TTC Survey Reports on Latin American Physicians’ Attitudes Toward Clinical Trials

Medical Innovation is ranked a Top Motivator for Participating in Clinical Trials by Investigators from Latin America and the US - September 29, 2011 - TTC LLC

SalesForce4Hire’s Kevin Schimelfenig to Serve on AdvaMed Annual Conference Panel

Custom Sales Solution Executive to Discuss Critical Funding Issues for Emerging Medical Device Companies - September 21, 2011 - SalesForce4Hire

Innovative Thought Leaders Address the 2011 Rocky Mountain Life Science Investor Conference in Denver

The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will host several keynote speakers who are shaping the future of bioscience. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO. - September 21, 2011 - Colorado BioScience Association

Nationally Accredited Drug and Alcohol Testing Company Opens in Altamonte Springs, FL

ARCpoint Labs provides a full range of screening services, including corporate wellness programs, federally mandated testing, and onsite workplace testing. - September 21, 2011 - ARCpoint Labs - Altamonte Springs

FEECO International Looks to Malaysia for Waste to Fertilizer Opportunities

FEECO travels to Malaysia and finds great opportunities in transforming waste into fertilizer for local crop production. - September 17, 2011 - Feeco International Australia

SalesForce4Hire Executive to Host AdvaMed 2011 Entrepreneur Bootcamp

Kevin Schimelfenig to Lead Panel Information on Capital Efficient Strategies for the Buyer, Seller and Investor - September 16, 2011 - SalesForce4Hire

The MicroStar Lab Ltd Receives ITAR Registration

The MicroStar Lab LTD, a leading Microbiological Industrial Testing Laboratory, is pleased to announce that they have received their International Traffic in Arms Regulations (ITAR) Registration. ITAR is a program directed by the US Department of State, regulating the export and import of U.S. - September 14, 2011 - The MicroStar Lab Limited

Advanced Pharma Finalizes Lease with UMLSTP

Advanced Pharma Finalizes Lease with UMLSTP

Advanced Pharma, a dedicated Phase I-IV comprehensive research facility, has finalized a lease with The University of Miami Life Science & Technology Park's (UMLSTP) developer, Wexford Miami, LLC. - September 08, 2011 - Advanced Pharma CR, LLC

More Than 4 of 5 Clinical Trial Sites Request That Sponsors Use Clinical Financial Services to Process Payments

Clinical Financial Services (CFS), the only company that offers comprehensive business and financial management services for the clinical trial industry, is pleased to announce the results of its Site Satisfaction Survey which highlights that more than 4 out of 5 respondents would request sponsors... - September 08, 2011 - Clinical Financial Services

2011 Rocky Mountain Life Science Investor and Partnering Conference Attracts More Than 30 International Investors to Denver September 21-22

More than 30 leading biotech, device, diagnostic and pharma investors from across the country and world will be coming to Denver to create the newest deals and shape the future landscape of the life science industry. The Rocky Mountain Life Science Investor & Partnering Conference (RMLIPC) is September 21-22 at the Brown Palace Hotel. - September 07, 2011 - Colorado BioScience Association

Sweden Based Prostalund to Increase Investments in the US BPH Market

To further enhance its position in the US market, the company has decided to establish a 100% owned US subsidiary under the name CoreTherm Medical, Inc. effective from September 1st 2011. The company is located in Oldsmar, Florida. - September 06, 2011 - CoreTherm Medical Inc.

Advanced Pharma Celebrates Two-Year Anniversary

Advanced Pharma CR, LLC, one of South Florida’s largest dedicated phases I-IV clinical research facilities, is proud to announce that it has marked the two-year anniversary of its founding. Samantha Amaba, President and co-founder, is thrilled with the company’s success. "Advanced... - September 02, 2011 - Advanced Pharma CR, LLC

World Experts Meet in Cambridge to Discuss Treatments for Down Syndrome

The treatability of Down Syndrome is gaining evidence and support, but remains the "holy grail" for parents and doctors. A rare gathering of expert scientists will plan the next stage in human treatments for Down syndrome. The wider context of the impact on people with Alzheimer's with be discussed. - September 01, 2011 - Down Syndrome Research Foundation UK

Advanced Orthopedics and Sports Medicine Institute in Freehold, N.J. Announces Scholarship Winner

The orthopedic surgeons of Advanced Orthopedics and Sports Medicine Institute in Freehold, Monroe, Jackson, and Wall, New Jersey recently awarded a $1000 scholarship to high school senior, Jeanne Russo of Farmingdale. - September 01, 2011 - Advanced Orthopedics and Sports Medicine Institute, PC

ImpactRx Appoints Gregory Ellis President and CEO

Former Rosetta Senior Partner Brings His Analytics Experience and Expertise to New Leadership Role - August 26, 2011 - ImpactRx, Inc

Colorado BioScience Association Serves as Catalyst in Assembling CEO Rountable Discussion for Senator Michael Bennet and FDA Commissioner Margaret Hamburg

The Colorado BioScience Association (CBSA) brought more than 35 industry CEOs together today to dialogue with Senator Michael Bennet and U.S. FDA Commissioner Margaret Hamburg at the Anschutz Medical Campus in Aurora. At Senator Bennet's request, CBSA designed today's session to share the bioscience industry's specific and unique needs in bringing innovative drugs and devices to market under current, often constraining, market conditions. - August 22, 2011 - Colorado BioScience Association

CannaLicense Partners with KindReviews.com to Help Medical Marijuana Patients Learn About Efficacy and Strains

CannaLicense has just announced that they have partnered with KindReviews.com to help medical marijuana patients learn about efficacy and strains. Cannalicense is a medical marijuana licensing company that works with residents of Colorado and Arizona to get a license, to treat their illnesses and... - August 19, 2011 - CannaLicense

CannaLicense Has a New Corporate Office in Denver

The medical marijuana licensing center, Cannalicense has announced the opening of their new corporate office in Denver, Colorado. The new corporate office is located at 2250 S Oneida Street, Suite 306. This change is in response to the increase in applicants since the approval for medical marijuana... - August 19, 2011 - CannaLicense

ImpactRx Announces Enhancements to BrandImpact Oncology

Data Capture Expanded to Directly Connect Biomarker Testing to Cancer Treatment - August 18, 2011 - ImpactRx, Inc

S.L.E. Lupus Foundation Brightens Days for 40 New York City Kids with Lupus and Their Families with Free Week at Camp Sunshine

S.L.E. Lupus Foundation Brightens Days for 40 New York City Kids with Lupus and Their Families with Free Week at Camp Sunshine

40 New York City children and teens with lupus and their families converge on Camp Sunshine for Lupus Week hosted by the S.L.E. Lupus Foundation. Located on Lake Sebago in Maine, Camp Sunshine offers the only program in the nation to address the impact of a life-threatening illness on every member of the immediate family. The S.L.E. Lupus Foundation raises private funds to send families selected by eligibility and need to Camp Sunshine each summer. - August 15, 2011 - S.L.E. Lupus Foundation

Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor Conference in Denver

The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO. - August 10, 2011 - Colorado BioScience Association

SalesForce4Hire® Releases White Paper on a "Shared Risk – Shared Reward" Sales Model

Leading Custom Sales Solutions Company Addresses Advantages of a Strategic Sales Partner Over Traditional Outsourced Sales Organizations - August 05, 2011 - SalesForce4Hire

Mitegen Announces Distribution of AP Innovation's Quick Puck Loader

Innovative Tool increases speed and reduces errors during puck loading - August 03, 2011 - MiTeGen, LLC

AbboMax Announces the Availability of New Mouse Anti-Desmoglein 3 (Dsg3) Monoclonal Antibody

Desmogleins are calcium-binding transmembrane glycoproteins, members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 protein has been identified as the autoantigen of the autoimmune skin blistering disease pemphigus vulgaris and plays important roles in human squamous cell cancer. - August 03, 2011 - AbboMax, Inc.

Breakthrough Indentation Yield Strength Test by Nanovea

Nanovea introduced its patent pending breakthrough method of reliably acquiring yield strength through indentation; ultimately replacing the traditional tensile testing machine for yield strength measurement. - July 30, 2011 - NANOVEA

Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says

A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Enhanced POP 2.0 Provides Custom Insight Into the Physician's Mindset at the Point of Promotion and Prescribing

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announces the rollout of POP 2.0, a proprietary, event-triggered survey tool utilized by the Company's iPhone-enabled longitudinal physician panels. Triggered by events already collected through the... - July 29, 2011 - ImpactRx, Inc

BioRegenerative Sciences, Inc. Releases L-Ease a Stem Cell, Antioxidant-Based Eye Drop for Cataract

The L-Ease eye drops contain a proprietary blend of SRM and antioxidants proven to protect eye tissue against the formation of opacities. - July 26, 2011 - BioRegenerative Sciences, Inc.

Imapact Rx Announces New Additions to Management Team

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announces that Rob Delghiaccio has joined ImpactRx as Senior Vice President of Business Development and Jim Cronin was promoted to Senior Vice President, Oncology Franchise. Rob Delghiaccio comes to... - July 22, 2011 - ImpactRx, Inc

BioRegenerative Sciences, Inc. Releases I-Ease PF, a Stem Cell-Based, Preservative-Free, Eye Drop for Dry Eye

BioRegenerative Sciences, Inc. Releases I-Ease PF, a Stem Cell-Based, Preservative-Free, Eye Drop for Dry Eye

A new preservative-free eye drop using stem cell technology to help alleviate dry eye. - July 20, 2011 - BioRegenerative Sciences, Inc.

BioRegenerative Sciences Releases Advanced, Anti-Aging Cosmeceutical Line Based on Patented, Stem Cell-Based Molecular Biotechnology

BioRegenerative Sciences Releases Advanced, Anti-Aging Cosmeceutical Line Based on Patented, Stem Cell-Based Molecular Biotechnology

The most effective anti-aging cosmeceuticals have been released by BioRegenerative Sciences, Inc. These new cosmeceuticals use stem cell-based molecular biotechnology to help heal the skin and thus produce beautiful skin. - July 12, 2011 - BioRegenerative Sciences, Inc.

ImpactRx Measure How Patient Brand Requests Drive Physician Treatment Decisions

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, offers pharmaceutical brand managers unique insight into the effectiveness of their direct-to-consumer promotional efforts. - July 08, 2011 - ImpactRx, Inc

Midwest Center for Clinical Research Recruits First Participants in Johnson & Johnson Study

Kansas City research center gains attention for the Midwest from global drug companies. - July 08, 2011 - Midwest Gastroenterology

New Virus Modification Approach to Creating Vaccines for Insect-Borne Diseases

A technology breakthrough that could have a major impact in the development of vaccines to preventive insect-borne diseases has been published in the June edition of Virology Journal, - July 07, 2011 - Arbovax Inc

Glissandra Skincare Inc. Announces Pre-Launch Registration for New Network Marketing Business Opportunity

Glissandra Skincare is pleased to announce the pre-launch of a new network marketing (also known as MLM or multi-level marketing) business opportunity featuring its successful line of groundbreaking anti-aging skincare products targeting the leading cause of skin aging: mitochondrial decay. - July 07, 2011 - Glissandra Skincare

DDC, the UK’s Leading DNA Testing Company, Successfully Completes Its UK Ministry of Justice Annual Review

DDC maintains the prestigious UK Ministry of Justice approval listing for DNA testing laboratories. - July 07, 2011 - DNA Diagnostics Centre

Recurrent Ulcers in a Patient with Post-Thrombotic Syndrome Treated with Triticum's Honey Dressings

Doctor Pereira Albino (vascular surgeon) wrote a case report titled: “Recurrent ulcers in a patient with post-thrombotic syndrome." This was published in the latest Wounds UK Journal (Vol.7, No.2). - July 07, 2011 - Mesitran

Clinical Evaluation of Triticum's Honey-Based Products for Lower Extremity Wounds in a Home Care Setting

Filip Kegels (RN) wrote a clinical research/audit article in the new Wounds UK Journal (Volume 7, no 2) titled: “Clinical evaluation of honey-based products for lower extremity wounds in a home care setting.” - July 06, 2011 - Mesitran

BioRegenerative Sciences Releases Breakthrough Hair Regrowth Product for Women

BioRegenerative Sciences Releases Breakthrough Hair Regrowth Product for Women

BioRegenerative Sciences, Inc. launches Hair Stemulating Complex for Women to regrow thinning hair. HSC uses a new patented technology featuring stem cell technology. - July 05, 2011 - BioRegenerative Sciences, Inc.

Modular Devices Inc. Helps to Quickly Restore Cardiac and Vascular Services to Joplin, MO

Modular Devices Inc. Helps to Quickly Restore Cardiac and Vascular Services to Joplin, MO

Modular Cath Lab installed at St. John’s mobile field hospital. - July 02, 2011 - Modular Devices Inc.

Feeco International Brings Quality in Granulation Equipment to the Australasia Region

The recent opening of a Feeco International, Inc. lab testing facility in Pakenham, Victoria, Australia means big things for the farming, mining, and biofuel industries of the Australasia Region. - July 01, 2011 - Feeco International Australia

Bacteria-Focused Treatment of Lyme Disease May be Incorrect

Clinical research done by Dr. David A. Jernigan at the Hansa Center for Optimum Health, suggests that in many of the people who experience long-term recovery from chronic Lyme disease, the bacteria and co-infections played only a secondary role in their recovery. - June 29, 2011 - Hansa Center for Optimum Health

Colorado BioScience Association Showcases Colorado's Bioscience Industry at BIO 2011 Conference in Washington DC, June 27-30

Colorado BioScience Association (CBSA) will head the Colorado Pavilion at the Biotechnology Industry Organization’s (BIO) International Convention in Washington DC, June 27-30. The Colorado Pavilion, located in booth # 2107 of the Exhibit Hall area, includes a number of companies and partners helping to grow the bioscience industry in the state. - June 29, 2011 - Colorado BioScience Association

Mitegen Awarded $250K NIH STTR Phase II Grant

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a phase II STTR (small business technology transfer program) award from the NIH (National Institute of Health) for the development of improved crystallization plates. - June 27, 2011 - MiTeGen, LLC

Clinical Trials in Russia. Year 2010.

The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor) and the Ministry of Health and Social Development of the Russian Federation (MoH) approved 492 new clinical trials of all types including local and bioequivalence studies during 2010, demonstrating a 15% decrease from the last year figure. - June 27, 2011 - Synergy Research Group

OSO BioPharmaceuticals Receives DEA Approval to Handle Controlled Substances

OSO BioPharmaceuticals Manufacturing, LLC, has been granted research and analytical licenses by the U.S. Drug Enforcement Administration (DEA) to handle Schedule II through V controlled substances. - June 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Press Releases 1,551 - 1,600 of 2,297